Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall

Alessandra Laricchia; Antonio Mangieri; Francesco Gallo; Azeem Latib; Andrea Fisicaro; Rita Conti; Angelo Squeri; Lorenzo Mantovani; Antonio Colombo; Francesco Giannini

doi:10.1016/j.carrev.2019.09.017

Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall

Alessandra Laricchia, Antonio Mangieri, Francesco Gallo, Azeem Latib, Andrea Fisicaro, Rita Conti, Angelo Squeri, Lorenzo Mantovani, Antonio Colombo, Francesco Giannini

Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

A 79-year-old man with heart failure was referred to our attention for a degenerated bio-Bentall Mitroflow 27. The Heart Team decided for a valve-in-valve (ViV) transcatheter aortic valve implantation with an Acurate neo M associated to coronary protection due to high risk of coronary obstruction (CO). Besides the supra-anular design, this case shows additional potential advantages of the Acurate neo in ViV procedures: the upper crown, which is meant to favor supra-anular anchoring, also let to cap the bioprosthesis leaflets and minimize the risk of CO; there is not any interference between the valve cage and the stents protruding into the aorta, avoiding potential stent crushing and assuming an easier future coronary engagement.

Original language	English (US)
Pages (from-to)	18-20
Number of pages	3
Journal	Cardiovascular Revascularization Medicine
Volume	21
Issue number	11
DOIs	https://doi.org/10.1016/j.carrev.2019.09.017
State	Published - Nov 2020

Keywords

Coronary obstruction
Coronary protection
Transcatheter aortic valve implantation
Valve-in-valve

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.carrev.2019.09.017

Cite this

@article{5bfe7c8bd606437881d3d52a03fa2c83,

title = "Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall",

abstract = "A 79-year-old man with heart failure was referred to our attention for a degenerated bio-Bentall Mitroflow 27. The Heart Team decided for a valve-in-valve (ViV) transcatheter aortic valve implantation with an Acurate neo M associated to coronary protection due to high risk of coronary obstruction (CO). Besides the supra-anular design, this case shows additional potential advantages of the Acurate neo in ViV procedures: the upper crown, which is meant to favor supra-anular anchoring, also let to cap the bioprosthesis leaflets and minimize the risk of CO; there is not any interference between the valve cage and the stents protruding into the aorta, avoiding potential stent crushing and assuming an easier future coronary engagement.",

keywords = "Coronary obstruction, Coronary protection, Transcatheter aortic valve implantation, Valve-in-valve",

author = "Alessandra Laricchia and Antonio Mangieri and Francesco Gallo and Azeem Latib and Andrea Fisicaro and Rita Conti and Angelo Squeri and Lorenzo Mantovani and Antonio Colombo and Francesco Giannini",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = nov,

doi = "10.1016/j.carrev.2019.09.017",

language = "English (US)",

volume = "21",

pages = "18--20",

journal = "Cardiovascular Revascularization Medicine",

issn = "1553-8389",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall

AU - Laricchia, Alessandra

AU - Mangieri, Antonio

AU - Gallo, Francesco

AU - Latib, Azeem

AU - Fisicaro, Andrea

AU - Conti, Rita

AU - Squeri, Angelo

AU - Mantovani, Lorenzo

AU - Colombo, Antonio

AU - Giannini, Francesco

PY - 2020/11

Y1 - 2020/11

N2 - A 79-year-old man with heart failure was referred to our attention for a degenerated bio-Bentall Mitroflow 27. The Heart Team decided for a valve-in-valve (ViV) transcatheter aortic valve implantation with an Acurate neo M associated to coronary protection due to high risk of coronary obstruction (CO). Besides the supra-anular design, this case shows additional potential advantages of the Acurate neo in ViV procedures: the upper crown, which is meant to favor supra-anular anchoring, also let to cap the bioprosthesis leaflets and minimize the risk of CO; there is not any interference between the valve cage and the stents protruding into the aorta, avoiding potential stent crushing and assuming an easier future coronary engagement.

AB - A 79-year-old man with heart failure was referred to our attention for a degenerated bio-Bentall Mitroflow 27. The Heart Team decided for a valve-in-valve (ViV) transcatheter aortic valve implantation with an Acurate neo M associated to coronary protection due to high risk of coronary obstruction (CO). Besides the supra-anular design, this case shows additional potential advantages of the Acurate neo in ViV procedures: the upper crown, which is meant to favor supra-anular anchoring, also let to cap the bioprosthesis leaflets and minimize the risk of CO; there is not any interference between the valve cage and the stents protruding into the aorta, avoiding potential stent crushing and assuming an easier future coronary engagement.

KW - Coronary obstruction

KW - Coronary protection

KW - Transcatheter aortic valve implantation

KW - Valve-in-valve

UR - http://www.scopus.com/inward/record.url?scp=85074462957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074462957&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2019.09.017

DO - 10.1016/j.carrev.2019.09.017

M3 - Article

C2 - 31669110

AN - SCOPUS:85074462957

SN - 1553-8389

VL - 21

SP - 18

EP - 20

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

IS - 11

ER -

Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this